$2.52
At close: Apr 14 EDT
$2.34
-0.18-7.14%
Pre-Market: 9:08 AM EDT
Comments
Loading...
Zepp Health Stock Guidance | NYSE:ZEPP | Benzinga
Zepp Health issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | ZEPP | Zepp Health | Q1 | 2025 | — | — | — | $40.00M | $45.00M | — | Get Alert |
| 08/21/2024 | ZEPP | Zepp Health | Q3 | 2024 | — | — | — | $45.00M | $60.00M | — | Get Alert |
| 05/20/2024 | ZEPP | Zepp Health | Q2 | 2024 | — | — | — | $40.00M | $55.00M | $72.49M | Get Alert |
| 03/18/2024 | ZEPP | Zepp Health | Q1 | 2024 | — | — | — | $42.00M | $49.00M | $72.60M | Get Alert |
| 11/20/2023 | ZEPP | Zepp Health | Q4 | 2023 | — | — | — | $82.24M | $116.50M | $204.42M | Get Alert |
| 08/21/2023 | ZEPP | Zepp Health | Q3 | 2023 | — | — | — | $82.74M | $110.33M | $179.52M | Get Alert |
| 05/23/2023 | ZEPP | Zepp Health | Q2 | 2023 | — | — | — | $94.65M | $123.77M | $155.70M | Get Alert |
| 03/21/2023 | ZEPP | Zepp Health | Q1 | 2023 | — | — | — | $86.99M | $108.74M | $125.08M | Get Alert |
| 11/21/2022 | ZEPP | Zepp Health | Q4 | 2022 | — | — | — | $154.64M | $189.78M | $204.50M | Get Alert |
| 08/25/2022 | ZEPP | Zepp Health | Q3 | 2022 | — | — | — | $179.16M | $223.94M | $303.42M | Get Alert |
| 05/24/2022 | ZEPP | Zepp Health | Q2 | 2022 | — | — | — | $170.37M | $205.07M | $270.61M | Get Alert |
| 03/17/2022 | ZEPP | Zepp Health | Q1 | 2022 | — | — | — | $117.69M | $156.92M | $228.72M | Get Alert |
| 12/31/2021 | ZEPP | Zepp Health | Q4 | 2021 | — | — | — | $251.16M | $274.71M | $292.78M | Get Alert |
| 11/16/2021 | ZEPP | Zepp Health | Q4 | 2021 | — | — | — | $271.60M | $310.39M | $385.05M | Get Alert |
| 08/19/2021 | ZEPP | Zepp Health | Q3 | 2021 | — | — | — | $247.81M | $278.78M | — | Get Alert |
FAQ
What is the most recent guidance for Zepp Health (ZEPP)?
There have been no specific sales or earnings guidance reported for Zepp Health in recent months.
Browse guidance and forecast on all stocks.